IL-17 cytokine family.

[1]  R. Wu,et al.  IL-17 Markedly Up-Regulates β-Defensin-2 Expression in Human Airway Epithelium via JAK and NF-κB Signaling Pathways1 , 2004, The Journal of Immunology.

[2]  B. Graham,et al.  Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. , 2004, American journal of respiratory and critical care medicine.

[3]  M. Kawaguchi,et al.  Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway. , 2004, The Journal of allergy and clinical immunology.

[4]  D. Hoover,et al.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. , 2004, Annual review of immunology.

[5]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[6]  A. Gurney,et al.  Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice1 , 2004, The Journal of Immunology.

[7]  M. Kawaguchi,et al.  Induction of C-X-C Chemokines, Growth-Related Oncogene α Expression, and Epithelial Cell-Derived Neutrophil-Activating Protein-78 by ML-1 (Interleukin-17F) Involves Activation of Raf1-Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase 1/2 Pathway , 2003, Journal of Pharmacology and Experimental Therapeutics.

[8]  D. Hoover,et al.  Many chemokines including CCL20/MIP‐3α display antimicrobial activity , 2003 .

[9]  P. Macklem,et al.  Airway wall remodeling: friend or foe? , 2003, Journal of applied physiology.

[10]  W. Pierzchała,et al.  Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. , 2003, Respiratory medicine.

[11]  L. Boulet,et al.  Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. , 2003, The Journal of allergy and clinical immunology.

[12]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[13]  Kotaro Suzuki,et al.  Mast cells produce interleukin-25 upon FcεRI-mediated activation , 2003 .

[14]  J. Shellito,et al.  Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection1 , 2003, The Journal of Immunology.

[15]  T. Moseley,et al.  Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.

[16]  V. Trajković,et al.  The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells , 2003, Cellular and Molecular Life Sciences CMLS.

[17]  J. Lötvall,et al.  A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α , 2003, European Respiratory Journal.

[18]  J. Lötvall,et al.  Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. , 2003, European journal of pharmacology.

[19]  S. Ferretti,et al.  IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger , 2003, The Journal of Immunology.

[20]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[21]  C. R. Lankford,et al.  A unique role for IL‐23 in promoting cellular immunity , 2003, Journal of leukocyte biology.

[22]  D. Danilenko,et al.  Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. , 2002, Blood.

[23]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[24]  R. Hromas,et al.  Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.

[25]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[26]  Katie Chan,et al.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[27]  T. Ohteki.  Critical role for IL-15 in innate immunity. , 2002, Current molecular medicine.

[28]  B. Medoff,et al.  IFN-γ-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma1 , 2002, The Journal of Immunology.

[29]  L. Onuchic,et al.  Activation of Extracellular Signal-regulated Kinase (ERK)1/2, but Not p38 and c-Jun N-terminal Kinase, Is Involved in Signaling of a Novel Cytokine, ML-1* , 2002, The Journal of Biological Chemistry.

[30]  A. Gurney,et al.  IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.

[31]  A. Gurney,et al.  Forced Expression of Murine IL-17E Induces Growth Retardation, Jaundice, a Th2-Biased Response, and Multiorgan Inflammation in Mice , 2001, The Journal of Immunology.

[32]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[33]  M. Kawaguchi,et al.  Modulation of bronchial epithelial cells by IL-17. , 2001, The Journal of allergy and clinical immunology.

[34]  G. Sledge,et al.  Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production1 , 2001, The Journal of Immunology.

[35]  J. Schroeder,et al.  Identification of a Novel Cytokine, ML-1, and Its Expression in Subjects with Asthma1 , 2001, The Journal of Immunology.

[36]  R. Homer,et al.  IL-11: insights in asthma from overexpression transgenic modeling. , 2001, The Journal of allergy and clinical immunology.

[37]  R. Kelley,et al.  IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.

[38]  Q. Hamid,et al.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.

[39]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[40]  J. Lötvall,et al.  IL‐17‐induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen‐activated protein (MAP) kinases , 2001, British journal of pharmacology.

[41]  A. Gurney,et al.  IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1* , 2001, The Journal of Biological Chemistry.

[42]  C. Albanesi,et al.  Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. , 2000, The Journal of investigative dermatology.

[43]  K Wathen,et al.  A Novel Cytokine Receptor-Ligand Pair , 2000, The Journal of Biological Chemistry.

[44]  K. Yamaguchi,et al.  Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction , 2000, The Journal of experimental medicine.

[45]  M. Matthay,et al.  Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. , 2000, American journal of respiratory and critical care medicine.

[46]  A. Gurney,et al.  Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Adunyah,et al.  Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. , 1999, Biochemical and biophysical research communications.

[48]  Natvig,et al.  Change in the Th1/Th2 Phenotype of Memory T‐Cell Clones from Rheumatoid Arthritis Synovium , 1999, Scandinavian journal of immunology.

[49]  J. Lötvall,et al.  Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. , 1999, American journal of respiratory and critical care medicine.

[50]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[51]  P. Miossec,et al.  IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. , 1999, Journal of immunology.

[52]  A. Miller,et al.  IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. , 1998, Journal of immunology.

[53]  R. de Waal Malefyt,et al.  Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. , 1998, The Journal of investigative dermatology.

[54]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[55]  J. Derry,et al.  Molecular characterization of the human interleukin (IL)-17 receptor. , 1997, Cytokine.

[56]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.

[57]  Shau-ku Huang,et al.  Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. , 2005, American journal of respiratory and critical care medicine.

[58]  R. Djukanović,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD , 2004 .

[59]  M. Kawaguchi,et al.  Structural and functional analysis of a new cytokine, ML-1 (interleukin-17F) , 2003 .

[60]  P. Hellings,et al.  Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. , 2003, American journal of respiratory cell and molecular biology.

[61]  M. Kawaguchi,et al.  Extracellular signal-regulated kinase (ERK)1/2 regulates interleukin (IL)-6 and 8 expression by a novel cytokine, ML-1 , 2002 .

[62]  J. Shellito,et al.  Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. , 2001, American journal of respiratory cell and molecular biology.

[63]  T. Betsuyaku,et al.  Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.